Key Highlights
- Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases to humans.
- The global veterinary medicine market recorded revenues of $33.43 billion in 2024, representing a compound annual growth rate (CAGR) of 5.8% between 2019 and 2024.
- The pharmaceutical segment accounted for the market's largest proportion in 2024, with total revenues of $17.91 billion, equivalent to 53.6% of the market's overall value.
- North America accounted for the largest share of 43.3% of the global veterinary medicine market in 2024.
Report Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the veterinary medicine market in the global
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global veterinary medicine market
- Leading company profiles reveal details of key veterinary medicine market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Global veterinary medicine market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Global veterinary medicine market by value in 2024?
- What will be the size of the Global veterinary medicine market in 2029?
- What factors are affecting the strength of competition in the Global veterinary medicine market?
- How has the market performed over the last five years?
- Who are the top competitors in the global's veterinary medicine market?
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Merck & Co Inc
- Zoetis Inc
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Inc

